share_log

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET)

MannKind | 8-K: MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET)

曼恩凱德生物醫療 | 8-K:MANNKIND CORPORATION公佈2024年第二季度財務業績:提供臨床開發最新電話會議,將於今天上午9點(美國東部時間)開始
美股SEC公告 ·  08/07 20:11
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息